SCARA3 and Alzheimer disease: During adipogenesis, although the deletion of Scara3 gene in AD-MSCs did not elevate the expression of Fabp4 compared to that in control group, it enhanced other adipogenic markers, such as Pparα, Pparγ, and Lpl (Figure 7A–7E).